Drug Topics
MAY 31, 2024
In an interview with Chris Schaffner, PharmD, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro-Woolley, Washington, he discussed his unique pharmacy operation with the help of coffee shop revenue.
STAT
MAY 31, 2024
More than three years ago, the National Institutes of Health launched a $1 billion-plus initiative to find the root causes and potential treatments for long Covid , the chronic disease that has quickly changed the lives of millions of Americans. But a lack of visible progress from the initiative, called RECOVER, has drawn months of criticism from patient advocates, researchers, and lawmakers, including at a Senate hearing last week on the NIH’s budget.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 31, 2024
According to a survey, 18.9% of respondents said that the person they knew who died of a drug overdose was a family member or close friend.
STAT
MAY 31, 2024
There are a lot of reasons why updated data on Pfizer’s Lorbrena, a treatment for non-small cell lung cancer, might not seem to be a big deal. The results are an update on the clinical trial that resulted in the Food and Drug Administration granting Lorbrena full approval in 2001, so in a sense they are not even that new. For Pfizer investors, Lorbrena isn’t that big a deal, either.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MAY 31, 2024
Researchers addressed the association between COVID-19 vaccination status and incidents of post-COVID condition.
Pharmacy Times
MAY 31, 2024
Almost half of independent pharmacy owners/managers participating in an NCPA survey said that ESI was the pharmacy benefit manager causing the most financial stress in Medicare Part D.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MAY 31, 2024
Topline results of QWINT-2 and QWINT-4 met the primary end point of change in hemoglobin A1c compared to degludec and glargine, respectively, for those with type 2 diabetes.
Drug Topics
MAY 31, 2024
Roche's self-collection kit allows women to screen for cervical cancer at home, offering an alternative to a visit to a healthcare provider and promoting early detection of the disease.
Fierce Pharma
MAY 31, 2024
When companies introduce an injectable version of an intravenously infused drug, better convenience with comparable efficacy is typically the goal. | When companies introduce an injectable version of an intravenously infused drug, better convenience with comparable efficacy is typically the goal. But to Johnson & Johnson’s surprise, a subcutaneous formulation of its lung cancer med Rybrevant proved to work better than the original infusion.
Drug Topics
MAY 31, 2024
The SpeedySwab COVID + FLU A&B Self-Test from Watmind is intended for at-home and point-of-care use and can simultaneously detect COVID-19, influenza A, and influenza B in 15 minutes.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
MAY 31, 2024
Stay updated with the latest clinical trials news from 27th to 31st May, featuring companies like Arcturus Therapeutics, AZ, Vesper Bio, Ultragenyx, and Incannex. Get insights into their latest developments and advancements in the field.
Drug Topics
MAY 31, 2024
Authors analyzed Section 804 of the Food, Drug, and Cosmetic Act (FDCA) allowing state-sponsored programs to bring Canadian drugs onto US soil.
Fierce Pharma
MAY 31, 2024
Just one week after Summit Therapeutics and Akeso’s bispecific antibody ivonescimab passed muster with Chinese regulators, the drug has pulled off another feat by staring down the PD-1 king Keytrud | In the phase 3 HARMONi-2 trial, solo ivonescimab delivered a statistically significant and clinically meaningful improvement in progression-free survival over Keytruda monotherapy.
Drug Topics
MAY 31, 2024
As health care technology advances and cyberattack threats loom large, researchers aimed to assess the effect of ransomware attacks on US health systems.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MAY 31, 2024
Pregnant people and new mothers who are being treated for opioid addiction often have to fight to keep their children out of the hands of child protective services. But it’s a fight they shouldn’t have to face. They’re active in treatment. They’re not using illegal drugs. Yet child protective services (CPS) often take their babies away — not because they’re unfit mothers, but because they’re being judged on falsehoods.
pharmaphorum
MAY 31, 2024
Novartis’ Scemblix could be headed for first-line use in chronic myeloid leukaemia after outperforming TKI drugs in the ASC4FIRST study presented at ASCO.
Fierce Pharma
MAY 31, 2024
With the FDA nod, Moderna's RSV vaccine becomes the company's second product to secure the FDA's backing.
STAT
MAY 31, 2024
Ionis Pharmaceuticals, a California company that pioneered a whole class of RNA-targeted medicines, reported on Friday that a pair of late-stage trials showed that its experimental therapy for hereditary angioedema benefitted patients — including those taking drugs currently on the market. In one of the Phase 3 trials, dubbed OASIS, patients with hereditary angioedema, a rare disease characterized by severe bouts of swelling, were given injections of donidalorsen either monthly or every t
Fierce Pharma
MAY 31, 2024
After Amgen’s KRAS confirmatory trial results were rejected by the FDA as uninterpretable, Bristol Myers Squibb has divulged details of its rival study. | Bristol Myers Squibb has divulged the details of Krazati's confirmatory trial. While the study doesn't share the same design problems as Amgen's rival KRAS program, it still leaves open questions about Krazati's regulatory outlook.
The Checkup by Singlecare
MAY 31, 2024
Is your sleep regularly disrupted by sweat-soaked pajamas or sheets from overheating? If so, night sweats may be to blame. The Mayo Clinic defines night sweats as repeated episodes of heavy sweating during sleep. Your perspiration may not be due to heat generated from thick bedding or a warm room. Instead, night sweats are usually caused by an underlying illness or medical condition.
Pharmacy Times
MAY 31, 2024
Study investigators hired undercover shoppers, and the results revealed more education is needed on the Syringe Service Program, which provides legal, clean over-the-counter (OTC) needles to whomever seeks them out.
Pharmaceutical Technology
MAY 31, 2024
The US FDA has granted RMAT designation for BlueRock Therapeutics' cell therapy, bemdaneprocel (BRT-DA01), for Parkinson's disease.
Pharmacy Times
MAY 31, 2024
Although this data seems to overwhelmingly suggest that cannabis use has negative impacts for individuals with multiple sclerosis (MS), listening to patients’ reasoning for using it is crucial.
pharmaphorum
MAY 31, 2024
Moderna has secured FDA approval for its RSV vaccine, setting up a three-way market battle with GSK and Pfizer.
Pharmacy Times
MAY 31, 2024
Women who received epidural analgesia during labor were less likely to experience severe maternal morbidity complications, such as heart attack or heart failure and sepsis.
Drug Topics
MAY 31, 2024
mRESVIA is the first mRNA vaccine approved for a disease other than COVID-19.
pharmaphorum
MAY 31, 2024
Gilead's TROP2 ADC Trodelvy has missed the target in another clinical trial, this time in urothelial carcinoma.
Pharmacy Times
MAY 31, 2024
The priority review of inavolisib is for treatment of patients with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
Drug Topics
MAY 31, 2024
Take a look back at the conference coverage you may have missed this month.
Pharmacy Times
MAY 31, 2024
Subcutaneous ocrelizumab can be delivered in approximately 10 minutes and deliver comparable clinical benefit and safety to the IV formulation.
Drug Topics
MAY 31, 2024
Check out a selection of our coverage from Mental Health Awareness Month.
Fierce Healthcare
MAY 31, 2024
Startup Plenful launched out of stealth seven months ago to tackle the labor challenges and administrative bottlenecks plaguing pharmacy operations. | Plenful, which developed an AI workflow automation platform to streamline pharmacy and healthcare operations, banked $17 million in series A funding to build out its infrastructure and fuel more product development.
Drug Topics
MAY 31, 2024
Check out these can’t-miss dermatology stories published this month.
Pharmacy Times
MAY 31, 2024
Quadruple therapies including immunotherapy agents show promise in treating patients with multiple myeloma.
Expert insights. Personalized for you.
187 
Let's personalize your content